These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients. Lapiński TW Arch Immunol Ther Exp (Warsz); 2001; 49(4):311-6. PubMed ID: 11726034 [TBL] [Abstract][Full Text] [Related]
29. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. Pham TN; Mercer SE; Michalak TI J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578 [TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of toll-like receptors and their pathways in viral hepatitis. Sawhney R; Visvanathan K Antivir Ther; 2011; 16(4):443-58. PubMed ID: 21685532 [TBL] [Abstract][Full Text] [Related]
31. Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. Villacres MC; Literat O; DeGiacomo M; Du W; Frederick T; Kovacs A J Viral Hepat; 2008 Feb; 15(2):137-44. PubMed ID: 18184197 [TBL] [Abstract][Full Text] [Related]
32. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Wang K; Liu H; He Y; Chen T; Yang Y; Niu Y; Chen H; Chen Y; Liu J; Ye F; Lin S; Zhao Y Hum Immunol; 2010 Oct; 71(10):950-6. PubMed ID: 20667457 [TBL] [Abstract][Full Text] [Related]
33. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man. Mozer-Lisewska I; Sikora J; Kowala-Piaskowska A; Kaczmarek M; Dworacki G; Zeromski J Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):295-302. PubMed ID: 20533094 [TBL] [Abstract][Full Text] [Related]
35. Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection. Ronit A; Salem M; Hartling HJ; Gaardbo JC; Ullum H; Gerstoft J; Nielsen SD APMIS; 2013 May; 121(5):437-46. PubMed ID: 23083518 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection. Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. Pontisso P; Gerotto M; Ruvoletto MG; Fattovich G; Chemello L; Tisminetzky S; Baralle F; Alberti A J Med Virol; 1996 Feb; 48(2):157-60. PubMed ID: 8835349 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection. Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406 [TBL] [Abstract][Full Text] [Related]
39. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection. Chu CM; Sheen IS; Liaw YF Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365 [TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection. Abou-Zeid AA; El-Sayegh HK Scand J Clin Lab Invest; 2011 Oct; 71(6):456-61. PubMed ID: 21623661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]